Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
UBS
Colorcon
Boehringer Ingelheim
Cerilliant
Cantor Fitzgerald
Farmers Insurance
AstraZeneca

Generated: August 18, 2018

DrugPatentWatch Database Preview

Insmed Company Profile

« Back to Dashboard

What is the competitive landscape for INSMED, and what generic and branded alternatives to INSMED drugs are available?

INSMED has one approved drug.



Summary for Insmed
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Insmed

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Insmed

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 5,200,509 ➤ Sign Up
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 5,681,818 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cerilliant
Fish and Richardson
Argus Health
Chinese Patent Office
Julphar
Covington
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.